Trial Profile
Drug Use Investigation of Kaletra.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Abbott Laboratories
- 29 Feb 2012 Actual patient number changed from 3887 to 1184 as reported by ClinicalTrials.gov.
- 25 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Mar 2010 New trial record